Evidence map›Paper›PMID 29740084›Full record

ArticleScientific reports2018

Periodical reactivation under the effect of caffeine attenuates fear memory expression in rats.

Lizeth K Pedraza, Rodrigo O Sierra, Fernanda N Lotz, Lucas de Oliveira Alvares

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Understanding the dynamic and destiny of memories.Neuroscience and biobehavioral reviews · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lizeth K PedrazaLaboratório de Neurobiologia da Memória, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. pedraza.lk@hotmail.com.
Rodrigo O SierraLaboratório de Neurobiologia da Memória, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Fernanda N LotzLaboratório de Psicobiologia e Neurocomputação, Biophysics Department, Biosciences Institute, 91.501-970, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-8245-6348
Lucas de Oliveira AlvaresLaboratório de Neurobiologia da Memória, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. lucas.alvares@ufrgs.br.ORCID 0000-0002-0472-903X
Universidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, several studies have shown that fear memories can be attenuated by interfering with reconsolidation. However, most of the pharmacological agents used in preclinical studies cannot be administered to humans. Caffeine is one of the world's most popular psychoactive drugs and its effects on cognitive and mood states are well documented. Nevertheless, the influence of caffeine administration on fear memory processing is not as clear. We employed contextual fear conditioning in rats and acute caffeine administration under a standard memory reconsolidation protocol or periodical memory reactivation. Additionally, potential rewarding/aversion and anxiety effects induced by caffeine were evaluated by conditioning place preference or open field, respectively. Caffeine administration was able to attenuate weak fear memories in a standard memory reconsolidation protocol; however, periodical memory reactivation under caffeine effect was necessary to attenuate strong and remote memories. Moreover, caffeine promoted conditioned place preference and anxiolytic-like behavior, suggesting that caffeine weakens the initial learning during reactivation through counterconditioning mechanisms. Thus, our study shows that rewarding and anxiolytic effects of caffeine during fear reactivation can change the emotional valence of fear memory. It brings a new promising pharmacological approach based on drugs widely used such as caffeine to treat fear-related disorders.

Indexed as

AnimalsAnti-Anxiety AgentsAnxietyCaffeineConditioning, ClassicalConditioning, PsychologicalDisease Models, AnimalEmotionsFearHumansMemoryRatsAnti-Anxiety AgentsCaffeine

Identifiers

PMID29740084
PMCPMC5940846
OpenAlexW2799741000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.